Senaparib
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Senaparib, covering 2021-12-16 to 2025-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer [Phase 2]